Dyslipidaemia, Hypercoagulability and the Metabolic Syndrome

Author(s): Anna I. Kakafika, Evagelos N. Liberopoulos, Asterios Karagiannis, Vasilios G. Athyros, Dimitri P. Mikhailidis

Journal Name: Current Vascular Pharmacology

Volume 4 , Issue 3 , 2006

Become EABM
Become Reviewer
Call for Editor


The metabolic syndrome is a clustering of risk factors including central obesity, insulin resistance, dyslipidaemia and hypertension. This syndrome is associated with increased risk of cardiovascular disease and is a common early abnormality in the development of type 2 diabetes. The pathogenesis of the syndrome has multiple origins. Obesity and sedentary lifestyle coupled with genetic factors interact to produce the syndrome. Here, we consider two components of the metabolic syndrome, dyslipidaemia and hypercoagulability.

Keywords: Metabolic syndrome, obesity, insulin resistance, dyslipidaemia, coagulation, ree fatty acids, high density lipoprotein, triglycerides

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [175 - 183]
Pages: 9
DOI: 10.2174/157016106777698432
Price: $65

Article Metrics

PDF: 1